What is Xeris Biopharma Holdings, Inc.'s interest paid?

Xeris Biopharma Holdings, Inc. (XERS) reported interest paid of $5.35M in Q1 2026.

What is the long-term trend for Xeris Biopharma Holdings, Inc.'s interest paid?

Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s interest paid has grown at a 38.9% compound annual growth rate (CAGR), from $7.29M to $27.12M.

What does interest paid mean?

Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.

Xeris Biopharma Holdings, Inc. XERS Interest Paid

Interest Paid at other companies

SavaraSVRA

$617K-53.4%

ANI PharmaceuticalsANIP

$7.82M-12.0%

Catalyst PharmaceuticalCPRX

$140K+35.9%

BridgeBio PharmaBBIO

$20.32M-12.7%

Arrowhead ResearchARWR

$4.75K—

BioCryst PharmaceuticalsBCRX

$6.08M-33.5%

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+18.3%

Enterprise value$1.42B+8.7%

P/E106.4×—

P/S4.1×-0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s interest paid?: Xeris Biopharma Holdings, Inc. (XERS) reported interest paid of $5.35M in Q1 2026.
What is the long-term trend for Xeris Biopharma Holdings, Inc.'s interest paid?: Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s interest paid has grown at a 38.9% compound annual growth rate (CAGR), from $7.29M to $27.12M.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.